Blogging Invest Patents San Diego 
Both Sides of the Table
OCTOBER 19, 2009
On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.
Xconomy
DECEMBER 14, 2018
The patent holder, the University of Toronto, gave companies the right to manufacture insulin. But the university also allowed them to patent the improvements they made, which enabled them to slap higher prices on each new version. In the nearly 100 years since insulin’s discovery, no generic version has become available in the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
MARCH 22, 2018
For the first 50 years of its existence, Bose Corporation invested primarily in in-house research and development to produce its lineup of high-end headphones, speakers, and other audio technologies. The privately held company made its first investment in a startup in late 2015, and last year it officially launched a corporate venture.
Xconomy
SEPTEMBER 14, 2018
The long running patent feud over CRISPR-Cs9 gene editing appears to be over, just as U.S. This week, a federal appeals court upheld a previous ruling handing a CRISPR-Cas9 patent to the Broad Institute of MIT and Harvard. biotech companies gear up for the first human tests of the landmark technology. Berkeley could appeal to the U.S.
Xconomy
MAY 30, 2016
I don’t know if it was their first investment, but they invested $75,000 in a researcher named Ken Olsen, at MIT. X: I read an article from 1998 that you were quoted in—it sounded like Stanford’s Niels Reimers helped MIT reorganize its patenting and licensing office in 1986 to make it more like Stanford’s model.
Xconomy
MARCH 2, 2018
These days, it’s not just Snow White’s stepmother who has a mirror that talks back. Thanks to augmented reality, Internet of Things, and data analytics technologies, more of us might be confronted with so-called “smart mirrors” the next time we try on clothes or accessories in a store.
Xconomy
NOVEMBER 8, 2019
Those drugs have now become the center of a patent dispute between the Foster City, CA, drug maker and the federal government. This week, the government filed a patent infringement suit in federal court against Gilead (NASDAQ: GILD ). A key part of that plan are HIV prevention drug made by Gilead Sciences.
Expert insights. Personalized for you.
274 
Let's personalize your content